September 30, 2020
A Georgia federal judge has cleared Boehringer Ingelheim Pharmaceuticals Inc. from a wrongful death suit alleging it failed to warn about the bleeding risks of its blood thinner Pradaxa, saying the woman leading the case didn't show that the company had new information that would have required it to add warnings.